London Biotech Pnds Medical Secures £308k Funding Round

Published

An estimated £308.1k has been raised by Pnds Medical Ltd in a funding round that values the London-based company at approximately £2.8m. The business operates in the biotechnology field, focusing on research and experimental development.

Incorporated in 2023, the firm specializes in bioinformatics, cell and tissue culture, and engineering. Its technical scope includes DNA and RNA research, gene and RNA vectors, and nanobiotechnology. The company also conducts biology research and investigates proteins, other molecules, and process techniques.

This latest investment brings the total capital raised in 2026 to £350.8k. This figure follows a 2025 period where the company secured £508.6k in funding. Financial records for the year ended 31 August 2025 show the business employed two people. The allotment of new shares took place in June.

Share this

Contact the editorial team at [email protected]